ISPE announced the results of its 2016 – 2017 International Board of Directors election, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the 2016 ISPE Annual Meeting & Expo, 18 – 21 September in Atlanta, Georgia USA.
“I am looking forward to collaborating with the incoming International Board of Directors to further the organization and advance the Society mission and vision,” said John Bournas, President and CEO, ISPE. “The new leadership team will not only provide invaluable guidance with regards to our strategic direction and efforts to support the biopharmaceutical manufacturing industry, but will continue the organization’s further globalization.”
The following pharmaceutical industry leaders have been elected to positions on the 2016 – 2017 ISPE International Board of Directors:
The following individual served in 2014 – 2016 and has been re-elected to a second two-year term:
In addition to those named above, the following Directors were elected in 2015 to serve a two-year term and will continue their service on the Board:
The 2015 – 2016 Board Chair will continue service on the Board in 2016 – 2017 as Immediate Past Chair:
Immediate Past Chair: Joseph Famulare, Vice President - Global Quality Compliance and
External Collaboration, Genentech/Roche, Pharma Technical Operations
View complete biographical information on all of ISPE’s International Board of Directors.
For more information, contact:
Senior Director, Marketing Communications, ISPE